HEPATOLOGY Podcast
Activity Overview
Episode publication activity over the past year
Episodes
The Severity Of Steatosis Influences Liver Stiffness Measurement In Patients With NAFLD
12 Jan 2016
Contributed by Lukas
Drs. Stephen A. Harrison and Salvatore Petta discuss the paper: The severity of steatosis influences liver stiffness measurement in patients with nona...
Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection
30 Nov 2015
Contributed by Lukas
Note: Published earlier in 2015. Drs. Stephen A. Harrison and Saleh A. Alqahtani discuss the paper: Safety and Tolerability of Ledipasvir/Sofosbuvir ...
Association of NAFLD with Subclinical Myocardial Remodeling and Dysfunction
17 Sep 2015
Contributed by Lukas
Drs. Stephen A. Harrison and Lisa B. VanWagner discuss the paper: Association of nonalcoholic fatty liver disease with subclinical myocardial remodeli...
The Role of Hepatic Resection in Liver Cancer
10 Sep 2015
Contributed by Lukas
Drs. Stephen A. Harrison and Sasan Roayaie discuss the paper: The Role of Hepatic Resection in the Treatment of Hepatocellular Cancer.
Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection
30 Jul 2015
Contributed by Lukas
Drs. Stephen A. Harrison and Saleh A. Alqahtani discuss the paper: Safety and Tolerability of Ledipasvir/Sofosbuvir With and Without Ribavirin in Pat...
The Impact of Phlebotomy in Nonalcoholic Fatty Liver Disease
23 Jun 2015
Contributed by Lukas
Drs. Stephen A. Harrison and Leon A. Adams discuss the paper: The Impact of Phlebotomy in Nonalcoholic Fatty Liver Disease: A Prospective, Randomized,...
Portal Hypertension and the Outcome of Surgery for HCC
23 Jan 2015
Contributed by Lukas
Drs. Stephen A. Harrison and Annalisa Berzigotti discuss the paper: Portal hypertension and the outcome of surgery for hepatocellular carcinoma in com...
Concordance Of Sustained Virological Response With Sofosbuvir - Containing Regimens For HCV
15 Jan 2015
Contributed by Lukas
Drs. Stephen A. Harrison and Eric M. Yoshida discuss the paper: Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with ...
Prioritizing HCC Patients -- Results Of The UNOS National Geographic Experiment
15 Jan 2015
Contributed by Lukas
Drs. Stephen A. Harrison and Karim J. Hazalun discuss the paper: Standing the test of time: Outcomes of a decade of prioritizing patients with hepatoc...
Enhanced MRI Prognosis Of Early Early Stage HCC
15 Jan 2015
Contributed by Lukas
Stephen A. Harrison, MD and Taro Yamashita, MD, PhD, discuss Gd-EOB-DTPA-enhanced MRI and Alpha-fetoprotein Predict Prognosis of Early Early Stage HCC...
Ursodeoxycholic Acid and PSC, Revisited
31 Oct 2014
Contributed by Lukas
Ursodeoxycholic acid (UDCA) is no longer recommended for management of adult patients with primary sclerosing cholangitis (PSC). We undertook a prospe...
Kidney Biomarkers and Differential Diagnosis of Patients with Cirrhosis and Acute Kidney Injury
27 Aug 2014
Contributed by Lukas
Acute kidney injury (AKI) is common in patients with cirrhosis and associated with significant mortality. The most common etiologies of AKI in this se...
NASH and HCC: A Growing Role for Liver Transplantation
10 Jul 2014
Contributed by Lukas
Nonalcoholic steatohepatitis (NASH) is currently the third leading indication for liver transplantation (LT) in the U.S. and is predicted to become th...
Distinguishing Immunoglobulin G4-associated Cholangitis from PSC
30 May 2014
Contributed by Lukas
The recent addition of immunoglobulin (Ig)G4-associated cholangitis (IAC), also called IgG4-related sclerosing cholangitis (IRSC), to the spectrum of ...
Ascites: Is the Etiology Cirrhosis or Cardiac?
02 Apr 2014
Contributed by Lukas
Heart failure (HF) is, after cirrhosis, the second-most common cause of ascites. Serum B-type natriuretic peptide (BNP) plays an important role in the...
Steroid Use In Acute Liver Failure
27 Feb 2014
Contributed by Lukas
Extensive population-based studies are much needed to accurately establish epidemiology and disease course in patients with primary sclerosing cholang...
Sclerosingcholangitis
13 Dec 2013
Contributed by Lukas
Extensive population-based studies are much needed to accurately establish epidemiology and disease course in patients with primary sclerosing cholang...
Cross-talk between Notch and Hedgehog Regulates Hepatic Stellate Cell Fate in Mice
03 Dec 2013
Contributed by Lukas
Liver repair involves phenotypic changes in hepatic stellate cells (HSCs) and reactivation of morphogenic signaling pathways that modulate epithelial-...
Minimal Hepatic Encephalopathy: Making Diagnosis Easier
04 Oct 2013
Contributed by Lukas
Minimal Hepatic Encephalopathy: Making Diagnosis Easier by AASLD
Predictive Models of Cirrhosis and HCC in CHB
13 Sep 2013
Contributed by Lukas
Integrating host and HBV characteristics, this study aimed to develop models for predicting long-term cirrhosis and hepatocellular carcinoma (HCC) ris...
Good long-term Outcome of Budd-Chiari Syndrome with a Step-wise Management
25 Jun 2013
Contributed by Lukas
Drs. Stephen Harrison and Susana Seijo Budd-Chiari syndrome (BCS) is a rare, life-threatening disease caused by obstruction of hepatic venous outfl...
Resection of Hepatocellular Cancer ≤2 cm: Results from Two Western Centers
26 Apr 2013
Contributed by Lukas
Drs. Stephen Harrison and Sasan Roayaie Asian series have shown a 5-year survival rate of ˜70% after resection of hepatocellular carcinoma (HCC) =...
Vitamin A Deficiency and Hepatitis C
09 Apr 2013
Contributed by Lukas
Drs. Stephen A. Harrison and Davide Bitetto Recent data suggest that vitamin A modulates the expression of type I interferon receptor enhancing the...
Sexual Transmission of Hepatitis C
09 Apr 2013
Contributed by Lukas
Drs. Stephen A. Harrison and Norah A. Terrault The efficiency of hepatitis C virus (HCV) transmission by sexual activity remains controversial. We ...
Acute Kidney Injury and Hospitalized Cirrhotics
09 Apr 2013
Contributed by Lukas
Drs. Stephen A. Harrison and Justin A. Belcher Acute kidney injury (AKI) is a common and devastating complication in patients with cirrhosis. Howev...
A New Non-invasive Test for NASH
28 Jan 2013
Contributed by Lukas
Drs. Stephen Harrison and Sudeep Tanwar Liver biopsy is the reference standard for the detection of nonalcoholic steatohepatitis (NASH) within nona...
Significance of Azathioprine Metabolites for the Maintenance of Remission in Autoimmune Hepatitis
18 Dec 2012
Contributed by Lukas
Drs. Stephen Harrison and Harpreet Dhaliwal Azathioprine (AZA) is used to maintain remission in autoimmune hepatitis (AIH), but up to 18% of patien...
Impact of disease severity on healthcare costs in patients with HCV
03 Dec 2012
Contributed by Lukas
Abstract Hepatitis C virus (HCV) infection increases total healthcare costs but the effect of the severity of liver disease associated with chronic h...
Activation of IKK/NFκB signaling induces liver fibrosis
04 Oct 2012
Contributed by Lukas
Dr. Stephen Harrison talks to Drs. Thomas Wirth and Yoshiaki Suname about the paper: Hepatic activation of IKK/NFκB signaling induces liver fibrosis ...
Model to estimate survival in ambulatory patients with hepatocellular carcinoma
04 Oct 2012
Contributed by Lukas
Drs. Stephen Harrison and W. Ray Kim discuss the paper: Model to estimate survival in ambulatory patients with hepatocellular carcinoma Abstract ...